Chinese Skullcap
Holistic tradition
Two very different plants share the name 'skullcap', and telling them apart is the whole point of this page. Chinese skullcap - Scutellaria baicalensis, huang qin - is a bitter East Asian root that has sat inside Traditional Chinese Medicine formulas for over a thousand years. American skullcap is a North American leafy nervine used for restlessness and sleep. They are routinely confused, including on product labels. Here is the honest version of the Chinese root: what tradition actually says, how thin the human evidence really is, the liver-injury reports we are not going to bury, and exactly what Health Canada permits. No hype, no BS.
In one minute
Chinese skullcap is the dried root of Scutellaria baicalensis, an East Asian mint-family plant known in Traditional Chinese Medicine as huang qin.
It is a completely different plant from American skullcap (Scutellaria lateriflora), the leafy herb used for restlessness and sleep - the two are constantly confused, and the difference matters.
Its golden colour and its chemistry come from flavones concentrated in the root: baicalin, baicalein and wogonin.
In traditional practice it is a formula herb. It is combined with other roots far more often than it is taken on its own.
Human research is genuinely thin. Most of what circulates online comes from cell-culture and animal work, not people.
Take the liver seriously. Combination supplements containing Chinese skullcap have been linked to cases of acute liver injury, and the root has real interaction potential with medications.
At a glance
History & natural history
'Skullcap' is one name doing the work of two entirely different plants, and the history only makes sense once you separate them.
The name, shared by both
Both plants get the name from the same feature: the small cap-shaped calyx at the base of the flower, which reminded early botanists of a medieval helmet or a Quaker bonnet. Scutella is Latin for a little dish. That shared name is the root of a confusion that persists on shop shelves today.
The North American plant
Scutellaria lateriflora is native to North America - a hardy mint-family perennial with small blue-purple hooded flowers, known variously as blue skullcap, side-flowering skullcap and, memorably, mad-dog skullcap. Native American peoples used it for nervousness, menstrual complaints and digestive and kidney problems, and European settlers learned it from them. In the 19th century the Eclectic physicians took it up as a nervine, prescribing it for what they called nervous tension and hysteria. The part used is the aerial growth - leaves and stems - and the tradition is a calming one.
The East Asian plant
Scutellaria baicalensis is a different story on a different continent. Native to East Asia and named for Lake Baikal, its thick root has been a staple of Chinese herbal medicine for well over a thousand years, recorded under the name huang qin - roughly, 'yellow reed', for the vivid golden colour of the cut root. In Traditional Chinese Medicine it belongs to the herbs that clear heat and dry dampness: bitter and cold in character, and therefore almost always paired with other roots that balance it. It is a component of classical formulas including xiao chai hu tang, the combination that travelled to Japan and became the Kampo formula sho-saiko-to.
Where the two stories collide
Both plants contain baicalin, which makes it easy for careless writing to treat research on one as if it applied to the other. Because American skullcap is the plant people search for when they want something calming, and Chinese skullcap root is the cheaper and more widely traded material, the Chinese root has repeatedly turned up where a buyer might have expected the American plant. The confusion is not harmless: the two have different risk profiles, different interaction potential, and separate Health Canada monographs.
The modern chapter
Western interest in the Chinese root arrived through its chemistry rather than its tradition. From the late 20th century onwards, researchers characterised its flavones - baicalin, baicalein and wogonin - and produced a large laboratory literature on their antioxidant, anti-inflammatory and anticancer activity in cells and animals. That literature is genuinely substantial. What it has not yet produced is much human evidence: as Memorial Sloan Kettering puts it, most studies have been done in the lab rather than in humans, and the herb has not been tested in clinical trials as a single agent. The other modern chapter is less flattering. Between 2010 and 2013, joint-support supplements containing Chinese skullcap generated a run of published case reports of acute liver injury, and the herb now carries a formal likelihood rating in the US LiverTox database. Both chapters belong in an honest history.
The science, graded honestly
We grade the evidence for every use so you can see the difference between "proven," "promising," and "traditional."
Cut a piece of dried huang qin and the inside is a vivid yellow. That colour is the chemistry. The root is unusually rich in a family of compounds called flavones, and three of them do most of the work in the research literature: baicalin, baicalein and wogonin. Reviews of the plant's phytochemistry have catalogued dozens of related compounds alongside terpenoids, volatile acids and polysaccharides.
## Baicalin, baicalein and wogonin
Baicalin is the most abundant. It is baicalein with a sugar attached - technically a glucuronide - and that sugar changes how your body handles it. Baicalin is poorly absorbed as-is; gut bacteria strip the sugar off, and the resulting baicalein is what actually crosses into the bloodstream, where much of it is then re-conjugated. Human pharmacokinetic work measuring baicalein and wogonin in urine after oral Scutellariae radix confirms these compounds do get absorbed, but the process is roundabout and depends partly on your gut microbiome - one honest reason results vary between people.
## What the laboratory work shows
In cell and animal models these flavones behave as antioxidants and as modulators of inflammatory signalling. Wogonin has shown anticonvulsant activity in animals, and some of the neuroprotective effects of these flavonoids appear to involve GABA receptor activity - the same broad system that sedatives act on. That last point is not a claim of benefit; it is a reason to be careful about combining this root with sedating medication.
## The important caveat
Almost all of this is preclinical. Cells in a dish are exposed to concentrations that a person swallowing a capsule will not reach. Direction of effect can even reverse with dose - baicalin has shown opposite effects on blood-vessel growth at low versus high concentrations in laboratory work. So the correct reading of the chemistry is: interesting, well characterised, and not the same thing as a proven effect in a human being.
Traditional Chinese Medicine use
Traditional useThis is the strongest and most honest thing that can be said about Chinese skullcap: it has a long, documented, continuous history of use as a formula herb in Traditional Chinese Medicine. That is a real credential. It is also a different kind of credential from a clinical trial, and we will not blur the two.
In TCM, huang qin belongs to the category of herbs that clear heat and dry dampness. Those terms describe a pattern - a way of characterising what is going on in a person - rather than a modern diagnosis, and the herb is selected because it fits that pattern. It is bitter and cold in character, which is why the classical formulas pair it with other roots that soften or direct it. It appears in well-known formulas including xiao chai hu tang, known in Japanese Kampo as sho-saiko-to, and in the heat-clearing combinations built around Coptis.
Canada's regulator handles it accordingly. Scutellaria baicalensis root appears in Health Canada's Traditional Chinese Medicine Ingredients monograph under the pharmacopoeial name Radix Scutellariae, common name huang qin. The permitted use wording is not a health benefit statement. For a single ingredient prepared as per a listed TCM reference text, the approved phrasing is 'Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine'; for other combinations it is 'Combination of Traditional Chinese Medicine Ingredients'. Doses must not exceed the maximum daily dose in the referenced TCM texts, the subpopulation is adults 18 and over, and the monograph carries a flat contraindication in pregnancy and breastfeeding. You can see the pattern in real licensed products too: Health Canada's licensed product database lists traditional pills containing S. baicalensis alongside a dozen or more other herbs, with claims written in TCM pattern language such as clearing toxic heat.
So: a genuine tradition, formally recognised in Canadian regulation as a tradition. Not a demonstrated modern health effect.
Health Canada NNHPD, Traditional Chinese Medicine Ingredients monograph (May 2025) ↗Joint comfort
PreliminaryJoint discomfort is where the small amount of actual human trial data on Chinese skullcap sits - and it comes with a large asterisk attached, because the same category of product produced the liver injury reports.
The trial most often cited is a 2014 study published in the Journal of Medicinal Food by Arjmandi and colleagues, which tested a combination of Scutellaria baicalensis and Acacia catechu extracts for short-term symptomatic relief of joint discomfort associated with osteoarthritis of the knee. Memorial Sloan Kettering's About Herbs summary of the evidence describes the result plainly: an herbal supplement containing S. baicalensis appeared to reduce symptoms of osteoarthritis, but it is not known whether the herb would exert similar effects by itself. That caveat is doing a lot of work. The product tested was a two-herb combination, so the result belongs to the combination, not to Chinese skullcap.
The same combination is the reason this page has a liver section. Flavocoxid (Limbrel), a 'medical food' for osteoarthritis containing baicalin from S. baicalensis plus Acacia catechu, was implicated in four cases of clinically apparent liver injury reported in Annals of Internal Medicine in 2012. Move Free Advanced, a joint supplement containing Chinese skullcap and black catechu, generated case reports of acute hepatocellular injury between 2010 and 2013. Earlier company-run studies of flavocoxid in osteoarthritis had reported minor side effects and no meaningful change in liver enzymes over twelve weeks, which is a reminder that short trials in modest numbers of people can miss a rare reaction entirely.
So the honest summary is uncomfortable but simple. There is a small, positive, short-term human signal for a combination product containing this root, and there is a documented pattern of rare liver injury from products in that same category. Neither is strong enough to recommend, and the second is serious enough that we would not point anyone toward this root for joints without a practitioner involved.
Arjmandi 2014, J Med Food ↗Antioxidant & inflammation
PreliminaryThis is the area with the most published research and the least human evidence - a combination worth understanding, because volume of papers is easily mistaken for weight of proof.
In cell culture, baicalin, baicalein and wogonin behave as antioxidants and interfere with inflammatory signalling pathways. Baicalin has shown anti-inflammatory effects in cigarette-smoke-induced inflammation models both in vitro and in animals, and baicalein reduced airway injury in animal models of allergen-driven airway inflammation. Memorial Sloan Kettering's review of the plant summarises the state of play in one sentence: most studies have been done in the lab rather than in humans, and suggest anti-inflammatory and antioxidant activity.
There are two reasons not to read across from that to yourself. The first is dose. Laboratory experiments expose cells directly to concentrations that oral dosing does not reproduce in human tissue, especially given that baicalin is poorly absorbed and depends on gut bacteria removing its sugar group before much gets into circulation. The second is direction. Effects from these compounds are not uniformly one-way: baicalin has shown dose-dependent opposite effects on blood-vessel growth in published work, increasing it at low concentrations and inhibiting it at high ones. A compound that flips direction with dose is a compound to be humble about.
A phase I study in healthy Chinese volunteers has examined the safety, tolerability and pharmacokinetics of baicalein tablets, and even there the researchers flagged something to watch - possible increases in high-sensitivity C-reactive protein and triglycerides that they recommended monitoring in future studies. That is the opposite direction from what an 'anti-inflammatory' framing would predict, and it is exactly why preliminary means preliminary.
Bottom line: a genuinely interesting body of laboratory pharmacology, and no basis for telling anyone that taking this root will reduce inflammation in their body.
MSK About Herbs: Scutellaria baicalensis ↗Blood sugar & metabolism
PreliminaryThere is one small human study here, and it is worth describing accurately because it is often stretched well beyond what it showed.
In 2020, Shin and colleagues published work in the American Journal of Physiology - Endocrinology and Metabolism looking at Scutellaria baicalensis given alongside metformin in people with type 2 diabetes. Memorial Sloan Kettering's summary calls it a preliminary study, and reports that the combination appeared to improve glucose tolerance, inflammation and gut microbiota. Note what that sentence does and does not say: the herb was added to an existing prescription drug, the study was preliminary, and the framing is 'appeared to'.
The gut microbiota angle is genuinely interesting from a mechanism point of view, because it runs in both directions. Your gut bacteria are what convert baicalin into the absorbable baicalein in the first place - so the microbiome shapes the herb's effect, and the herb may in turn shape the microbiome. That is a plausible loop. It is not a demonstrated clinical benefit.
The practical caution matters more than the finding. If you take medication for blood sugar, adding an herb with possible glucose-modifying effects is not a neutral act. Health Canada treats this seriously enough that its TCM Ingredients monograph requires combinations with potential additive glucose-modifying effects to be submitted as a higher-tier Class III application rather than waved through. Do not add this root to a diabetes regimen without your prescriber knowing, and do not reduce medication on the strength of an herb.
We do not make a blood sugar claim for this product, and neither does Health Canada's route for this ingredient.
Shin 2020, Am J Physiol Endocrinol Metab ↗Calm, stress & sleep
Traditional useMost people who search for 'skullcap benefits' are looking for a calming herb. They are looking for the other plant. We are including this entry precisely so that the record is straight rather than because Chinese skullcap has a calming reputation to defend.
The nervine tradition belongs to American skullcap, Scutellaria lateriflora - a North American plant used by Native American peoples and later adopted by 19th-century Eclectic physicians for nervousness and tension, prepared from the aerial parts rather than the root. That is the species with the traditional restlessness-and-sleep role, and it is the species Health Canada's separate Skullcap monograph covers when it permits traditional herbal wording about relieving restlessness and nervousness. Even for that plant the modern human evidence is modest: a 2014 randomised, double-blind, placebo-controlled crossover study in Phytotherapy Research gave 43 healthy volunteers 350 mg of S. lateriflora or placebo three times daily for two weeks each and found no significant difference on the Beck Anxiety Inventory in a largely non-anxious group, though total mood disturbance did fall significantly from baseline on the herb.
Chinese skullcap root is a different proposition. It is not classified in Traditional Chinese Medicine as a calming or spirit-settling herb; it sits in the heat-clearing, damp-drying category. There is no meaningful human evidence that it relieves anxiety or improves sleep. What does exist is laboratory work suggesting some of its flavonoids interact with GABA receptor activity - the broad system that benzodiazepines and other sedatives act on - and wogonin has shown anticonvulsant activity in animals.
That laboratory finding is a caution, not a selling point. If a compound plausibly touches sedative pathways, the sensible conclusion is to be careful about combining the root with sleeping pills, benzodiazepines, alcohol or other sedating medication - not to conclude that it will calm you down. Health Canada's TCM monograph points the same way, requiring combinations with potential additive sedative effects to go through a higher-tier review.
If calm is what you are after, buy the plant with the calming tradition behind it, and read the Latin name before you do.
Brock 2014, Phytotherapy Research (American skullcap, S. lateriflora) ↗Chinese skullcap and American skullcap are not the same plant
This is the single most important thing to understand before you buy anything labelled 'skullcap', and it is the thing most often got wrong - by shops, by bloggers, and sometimes by the labels themselves.
There are more than 200 species in the Scutellaria genus. Two of them are sold as supplements, and they are not interchangeable. They come from different continents, use different parts of the plant, have different chemistry, different traditional uses, and different regulatory status in Canada.
Chinese skullcap - Scutellaria baicalensis (huang qin)
Native to East Asia, not North America.
The medicinal part is the root, dug up and dried. It is dense, golden-yellow inside, and intensely bitter.
Its signature compounds are the flavones baicalin, baicalein and wogonin.
In Traditional Chinese Medicine it is a 'clear heat, dry damp' herb, used inside multi-herb formulas.
In Canada it sits in Health Canada's Traditional Chinese Medicine Ingredients monograph as Radix Scutellariae, where the permitted wording is TCM-theory framing, not a symptom claim.
American skullcap - Scutellaria lateriflora
Native to North America, with small blue-purple hooded flowers.
The medicinal part is the aerial parts - the leaves and stems above ground, not the root.
Traditionally a nervine, used by Native American peoples and later by 19th-century Eclectic physicians for nervousness and tension.
In Canada it has its own Health Canada monograph, which is the one that permits the traditional restlessness-and-nervousness wording you will see on American skullcap products.
Why the mix-up happens
Both plants are called 'skullcap', for the same reason: the little cap-shaped calyx on the flower that looks like a medieval helmet. Both contain baicalin, which lets careless writers treat research on one as if it applied to the other. And because American skullcap is the calming herb people search for, Chinese skullcap - a cheaper, more widely traded root - has repeatedly turned up in products where a buyer might reasonably have expected the American plant.
Why it is a safety issue, not a pedantry issue
If you take Chinese skullcap root expecting a gentle calming herb, you are taking something with a different risk profile, different interaction potential, and a documented association with liver injury in combination products. Adulteration has also been a real problem in this corner of the market: analyses of suspected skullcap liver-injury cases have found germander (Teucrium) substituted for skullcap - germander being a genuinely hepatotoxic plant.
The practical rule: read the Latin binomial and the plant part. 'Scutellaria baicalensis, root' and 'Scutellaria lateriflora, aerial parts' are two different purchases. If a label just says 'skullcap', you do not actually know what you have bought.
Who reaches for it - and who should not
Chinese skullcap is not a general wellness powder, and we would rather say that plainly than sell it as one.
It tends to suit
People working within a Traditional Chinese Medicine framework, usually with a practitioner, where huang qin is one component of a formula chosen for a particular pattern.
Home formulators and herbalists who want a concentrated, well-characterised root to build into their own blends, capsules or tinctures.
Practitioners and supplement makers buying bulk material with a Certificate of Analysis.
It is a poor fit if
You are looking for a calming or sleep herb. That is American skullcap's traditional territory, not this plant's. Buying the wrong species is the single most common mistake here.
You are pregnant or breastfeeding. Health Canada's TCM Ingredients monograph carries a flat contraindication: do not use if you are pregnant or breastfeeding.
You are under 18. The monograph's dosing applies to adults 18 and over.
You have any liver condition, or you drink heavily, or you are already taking something known to stress the liver.
You take prescription medication - particularly blood thinners, statins, sedatives, or drugs with a narrow safety margin. Talk to your prescriber first, not afterwards.
Set expectations honestly
This is a bitter, traditional formula herb with a thin human evidence base. If you are trying it, treat it as a considered experiment inside a broader plan, ideally with someone qualified watching - not as a supplement you take indefinitely because it seemed like a good idea.
Huang qin is a formula herb, not a solo act
In more than a thousand years of recorded use, Chinese skullcap has rarely been taken alone. It is a component. In Traditional Chinese Medicine it is classed among the herbs that clear heat and dry dampness, and it is chosen for a pattern rather than a symptom - then paired with other roots that temper it, direct it, or balance its cold, bitter character.
You can see this in the classical formulas it belongs to. Huang qin appears in xiao chai hu tang, the formula known in Japanese Kampo as sho-saiko-to, which is itself the subject of a research literature separate from the single herb. It appears alongside Coptis in the heat-clearing formulas. And it turns up in modern licensed products in Canada the same way: search Health Canada's Licensed Natural Health Products Database and you will find Scutellaria baicalensis listed as one medicinal ingredient among fifteen or more in a traditional pill, with the permitted claim written in TCM pattern language rather than as a symptom benefit.
This has three practical consequences.
First, evidence about a formula is not evidence about the herb. When you read that a Chinese skullcap preparation helped with something, check whether the study used the root on its own or a multi-ingredient product. Almost always it is the latter, and the effect - good or bad - cannot be cleanly assigned to this one root.
Second, self-prescribing single herbs from a formula tradition removes the safeguards that tradition built in. The balancing herbs are there for a reason.
Third, if you are taking it, a registered TCM practitioner or herbalist is the right person to talk to about how much, how long, and alongside what. Health Canada's own monograph reinforces the point - it directs users to ask a practitioner before prolonged use, and requires a Class III submission for combinations with additive sedative, blood-pressure-lowering or glucose-modifying effects.
— Health Canada Licensed Natural Health Products Database - example TCM formula containing S. baicalensis
The liver question, told straight
We would rather you read this from us than find it later. Chinese skullcap has a documented association with drug-induced liver injury, and it deserves more than a footnote.
What actually happened
Between 2010 and 2013, doctors in the United States published a series of case reports describing acute liver injury in people taking joint-support supplements that contained Chinese skullcap together with black catechu (Acacia catechu) - the best-known being formulations of Move Free Advanced. Patients typically developed jaundice within one to three weeks of starting the product; in one case there were also lung infiltrates alongside the hepatitis. A separate 'medical food' for osteoarthritis, flavocoxid (Limbrel), which contained baicalin from Scutellaria baicalensis plus Acacia catechu, was linked to four cases of clinically apparent liver injury reported in Annals of Internal Medicine in 2012. Individual case reports of injury from Chinese skullcap-containing supplements have continued to appear, including an Australian report in 2019 involving a 400 mg supplement.
In nearly all reported cases the injury was hepatocellular, moderate in severity, and resolved within one to three months of stopping the product. One patient's injury returned when the supplement was restarted - a rechallenge, which is the strongest signal you get short of a trial.
How the experts grade it
LiverTox, the US National Institute of Diabetes and Digestive and Kidney Diseases reference on drug-induced liver injury, gives skullcap a likelihood score of B: 'very likely but rare cause of clinically apparent liver injury'. It notes that Chinese skullcap is a different species from North American skullcap but may also have adverse effects on the liver.
The honest counterweight
The picture is not one-sided, and we will not pretend it is. Most of these cases involved multi-ingredient products, so isolating this one root is difficult. Some historic skullcap liver-injury cases turned out to involve germander adulteration or mislabelling. A 2019 review in Medical Hypotheses argued there is no convincing evidence that Scutellaria baicalensis itself causes liver injury. And in traditional Chinese practice the root has actually been used with the liver in mind, not against it.
What to do with all that
Rare is not never, and 'unclear causality' is not 'safe'. The reasonable position is caution rather than alarm: do not use it if you have a liver condition, do not stack it with other liver-stressing supplements or heavy alcohol, keep courses short rather than open-ended, and stop immediately and see a doctor if you develop yellowing of the eyes or skin, dark urine, unusual fatigue, nausea or right-sided abdominal pain.
What we're actually allowed to say
Myth or fact?
Tap each one to see the verdict.
They are two different plants and treating them as one is a safety problem, not a naming quibble. Chinese skullcap is Scutellaria baicalensis, an East Asian species whose dried root is used; American skullcap is Scutellaria lateriflora, a North American species whose aerial parts are used. Different continent, different plant part, different chemistry, different traditional role, and different Health Canada monographs - the traditional restlessness-and-nervousness wording belongs to the American plant, while the Chinese root is handled under the Traditional Chinese Medicine Ingredients monograph. LiverTox states it directly: there are more than 200 Scutellaria species with different components, activities and potential toxicities, and Chinese skullcap is a different species from North American skullcap. Adulteration has compounded the confusion - analyses of suspected skullcap liver-injury cases have found the genuinely hepatotoxic plant germander substituted for skullcap. Always buy on the Latin binomial and the plant part, never on the word 'skullcap' alone. LiverTox: Skullcap (NIDDK) ↗
Both halves of that sentence need unpicking. It is true that reviews of Scutellaria baicalensis describe hepatoprotective activity in laboratory and animal models, and that it has been used traditionally with the liver in mind. It is also true that supplements containing Chinese skullcap have been linked to real cases of acute liver injury in people. LiverTox records several reports and small case series of acute liver injury with jaundice arising after starting supplements containing S. baicalensis, and gives skullcap an overall likelihood score of B - very likely but rare cause of clinically apparent liver injury. The best-documented cases involved joint-support combination products such as Move Free Advanced and the medical food flavocoxid, with injury usually appearing within one to three weeks to three months and resolving after stopping. Causality is not airtight - most cases involved multi-ingredient products, and a 2019 review argued the evidence against the herb itself is not convincing - but 'protective in a dish' has never been a guarantee of 'harmless in a person'. LiverTox: Skullcap (NIDDK) ↗
This root has some of the more concrete interaction evidence in the herbal world, including an actual human study. In 2008, Fan and colleagues published a trial in Clinical Pharmacology & Therapeutics in which 18 healthy volunteers took baicalin tablets three times daily for 14 days alongside rosuvastatin; baicalin reduced blood levels of the statin, a drug handled by the OATP1B1 transporter. Memorial Sloan Kettering lists statins accordingly under 'do not take if'. Beyond that: laboratory work shows wogonin inhibits the CYP1A2 and CYP2C19 enzymes that clear many prescription drugs; baicalein, baicalin and wogonin inhibit solute carrier transporters that move drugs into cells; and baicalin has antiplatelet and anticoagulant activity in lab models, so blood thinners are a flagged concern. Clinical relevance for most of these is still undetermined - but 'undetermined' is a reason to tell your prescriber, not a reason to relax. Health Canada's TCM monograph likewise requires you to consult a practitioner before use if you take prescription medications. MSK About Herbs: Scutellaria baicalensis - herb-drug interactions ↗
Two errors stacked on top of each other. First, the calming reputation belongs to American skullcap (Scutellaria lateriflora), not to the Chinese root - and even there the human evidence is modest: a 2014 randomised, double-blind, placebo-controlled crossover study of 43 healthy volunteers found no significant difference from placebo on the Beck Anxiety Inventory, with a significant improvement only on a broader mood measure. Second, Chinese skullcap is not classified as a calming herb in Traditional Chinese Medicine at all; it belongs to the heat-clearing, damp-drying category. What does exist is laboratory work suggesting some of its flavonoids influence GABA receptor activity, and that is best read as a caution about combining it with sedatives, alcohol or sleeping medication rather than as a benefit. Nothing here supports comparing a bitter traditional root to a prescription anxiolytic, and we would not make that comparison. Brock 2014, Phytotherapy Research (American skullcap) ↗
The laboratory findings are real and the conclusion drawn from them is not. Memorial Sloan Kettering's review notes that extracts from this herb cause cell death in some cancer cell lines, but that human data are lacking and S. baicalensis has not been studied in clinical trials as a single agent - only within multi-herb formulations such as PC-SPES and sho-saiko-to. MSK also flags something the marketing never mentions: some compounds in the herb may have opposite effects, with baicalin showing dose-dependent dual behaviour on blood-vessel growth, increasing it at low concentrations and inhibiting it at high ones. Cell-line results are a starting point for research, not evidence about people. If you are living with cancer, this is a conversation for your oncology team before anything else - herb-drug interactions matter enormously alongside treatment, and this root has documented interaction potential. MSK About Herbs: Scutellaria baicalensis ↗
How to use it
Common forms
How much
There is no single approved consumer dose for Chinese skullcap in Canada, and inventing one would be misleading. Health Canada's Traditional Chinese Medicine Ingredients monograph does not set a number for this herb: it says the quantity must not exceed the maximum daily dose specified by the listed TCM reference texts, accounting for additive effects between ingredients of similar action, and it applies only to adults 18 years and older. Directions for use are likewise 'as specified by referenced texts'. Traditional decoction quantities are described in gram amounts of dried root and are not interchangeable by weight with a concentrated extract - a 10:1 extract concentrates ten parts root into one, so a much smaller measure is used. With our 10:1 root extract powder, a common starting point is around 1/4 teaspoon daily, worked into a blend, a warm drink or your own capsules; because the root is intensely bitter, most people encapsulate it or combine it with other herbs. Keep courses short rather than open-ended - the monograph directs you to ask a health care practitioner before prolonged use - and treat this as a herb to dose with a registered TCM practitioner or herbalist rather than by guesswork.
As a tea, tincture or capsule.
With this herb, checking the label is a safety step, not a quality preference. Five things to confirm:
The Latin binomial. It must say Scutellaria baicalensis. If it just says 'skullcap', or says Scutellaria lateriflora, you are looking at a different plant - the American nervine, not the Chinese root.
The plant part. It must say root (or Radix Scutellariae, or huang qin). Chinese skullcap medicine is made from the root; American skullcap uses the aerial parts. A 'skullcap herb' or 'aerial parts' label is not this plant.
The extract ratio. A 10:1 extract is ten parts dried root concentrated into one. Ratios are not potency claims, but they tell you how to compare products - and they tell you not to substitute extract for raw root gram-for-gram.
Third-party testing with a published Certificate of Analysis. Heavy metals at minimum. Given the documented history of germander adulteration in the skullcap trade, verified botanical identity matters more here than in most categories.
What the claims say. If a product uses Chinese skullcap but sells you calm, sleep or anxiety relief, someone has confused the species - or is hoping you will. In Canada there is no approved claim of that kind for Scutellaria baicalensis.
Frequently asked questions
Straight answers to the things people actually ask.
Chinese skullcap is the dried root of Scutellaria baicalensis, a mint-family plant native to East Asia. In Traditional Chinese Medicine it is called huang qin, and under its pharmacopoeial name Radix Scutellariae it appears in Health Canada's Traditional Chinese Medicine Ingredients monograph. The root is bitter and golden-yellow inside, a colour that comes from its flavones - baicalin, baicalein and wogonin. In traditional practice it belongs to the herbs that clear heat and dry dampness, and it is almost always used inside a multi-herb formula rather than on its own.
No, and this is the most important thing to get right. Chinese skullcap is Scutellaria baicalensis and the part used is the root; American skullcap is Scutellaria lateriflora and the part used is the aerial parts - leaves and stems. Different continents, different plant parts, different traditional roles, and different Health Canada monographs. American skullcap is the calming nervine with the traditional restlessness-and-sleep wording; Chinese skullcap is a TCM formula root. LiverTox notes there are more than 200 Scutellaria species with different components, activities and potential toxicities. If a label only says 'skullcap', you do not know which plant you have - check the Latin name and the plant part.
It deserves genuine caution. LiverTox, the US NIDDK reference on drug-induced liver injury, gives skullcap a likelihood score of B - very likely but rare cause of clinically apparent liver injury - and records several reports and small case series of acute liver injury with jaundice after starting supplements containing Scutellaria baicalensis. The best-documented cases came from joint-support combination products containing Chinese skullcap with black catechu, such as Move Free Advanced, and from flavocoxid (Limbrel), a medical food containing baicalin plus Acacia catechu, which was linked to four cases reported in Annals of Internal Medicine in 2012. Injury typically appeared within weeks to a few months and resolved after stopping. Causality is not fully settled - most cases involved multi-ingredient products, and one 2019 review argued the evidence against the herb itself is unconvincing - but the sensible response is caution: avoid it if you have any liver condition, do not stack it with other liver-stressing supplements or heavy alcohol, keep use short rather than open-ended, and stop and see a doctor immediately if you notice yellowing of the eyes or skin, dark urine, unusual fatigue, nausea or right-sided abdominal pain.
There is no single approved consumer dose in Canada, and we would be misleading you if we invented one. Health Canada's Traditional Chinese Medicine Ingredients monograph does not set a number for this herb; it says the quantity must not exceed the maximum daily dose specified by the listed TCM reference texts, taking additive effects between ingredients into account, and it applies to adults 18 years and older. In practice that means the right dose depends on the preparation, the formula it sits in, and who prescribed it. Our product is a 10:1 concentrated root extract, and a common starting point is about 1/4 teaspoon daily worked into a blend, a warm drink or your own capsules - but concentrated extracts are not interchangeable by weight with plain dried root, and this is genuinely a herb to use with a registered TCM practitioner or herbalist rather than by guesswork. The monograph also directs you to ask a practitioner before prolonged use.
Yes, and this is one of the better-documented herb-drug interaction stories. In a 2008 study in Clinical Pharmacology & Therapeutics, 18 healthy volunteers taking baicalin tablets three times daily for 14 days had reduced blood levels of the statin rosuvastatin, which is handled by the OATP1B1 transporter. Memorial Sloan Kettering therefore lists statins under 'do not take if', along with blood thinners - baicalin shows antiplatelet and anticoagulant activity in laboratory models - and CYP450 substrate drugs, since wogonin inhibits the CYP1A2 and CYP2C19 enzymes in vitro. Laboratory work also shows these flavones inhibiting solute carrier transporters that move drugs into cells. Clinical relevance for several of these is still undetermined, which is precisely why your prescriber should know. Health Canada's TCM monograph also requires you to consult a health care practitioner before use if you are taking prescription medications, and treats combinations with additive sedative, blood-pressure-lowering or glucose-modifying effects as needing higher-tier review.
No. Health Canada's Traditional Chinese Medicine Ingredients monograph - the route under which Scutellaria baicalensis root is regulated in Canada - carries a flat contraindication for all products under it: do not use if you are pregnant or breastfeeding. The same monograph limits use to adults 18 years and older. That is not a hedge on our part; it is the regulatory position, and we follow it.
Not what most people expect. Scutellaria baicalensis root is listed in Health Canada's Traditional Chinese Medicine Ingredients monograph as Radix Scutellariae (huang qin), and the permitted use wording there is framing, not a benefit claim. For a single ingredient prepared according to one of the listed TCM reference texts, the approved phrasing is 'Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine'; for other combinations it is 'Combination of Traditional Chinese Medicine Ingredients'. Licensed multi-herb products containing it carry claims written in TCM pattern language - phrases about clearing heat, for example - rather than modern symptom claims. There is no approved Canadian claim that Chinese skullcap relieves anxiety, aids sleep, supports joints, boosts immunity or protects the liver. The traditional restlessness-and-nervousness wording you may have seen belongs to a different Health Canada monograph covering American skullcap, Scutellaria lateriflora.
Bitter and earthy - genuinely bitter, in the way a heat-clearing root is supposed to be. Very few people enjoy it stirred into a drink. In practice most people either encapsulate it at home or blend it with other herbs, which also happens to be closer to how huang qin has traditionally been used: as one component of a formula rather than a solo powder. Our version is a 10:1 concentrated root extract of Scutellaria baicalensis, meaning ten parts dried root are concentrated into one part powder, so a small measure goes a long way. Home formulators and practitioners are the main audience for it. If you are new to the herb, work with a registered TCM practitioner or herbalist rather than experimenting on your own.
About our Chinese Skullcap Extract 10:1
What we sell is a 10:1 concentrated extract of Scutellaria baicalensis root - the correct plant and the correct plant part for huang qin. Ten kilograms of dried root are concentrated into one kilogram of fine powder.
## What that means in practice
A 10:1 ratio is a concentration, not a potency claim. Roughly speaking, 1/4 teaspoon of a 10:1 extract stands in for a considerably larger quantity of plain dried root - which is why the dose looks small next to the gram-scale quantities you see in traditional decoction texts, and why you should not simply substitute one for the other by weight.
## What it is like
Bitter and earthy, with the root's characteristic golden colour. Most people do not enjoy it in a drink. It is far more commonly encapsulated at home or blended into a formula with other herbs, which is also closer to how it has traditionally been used.
## How we handle quality
It is third-party tested for heavy metals, with the Certificate of Analysis published on the product page. It is vegan and non-GMO, with no fillers, binders or preservatives, and it is made in Canada from imported ingredients. We list the Latin binomial and the plant part on the label precisely because 'skullcap' on its own does not tell you what you have bought.
## What we do not claim
We do not make a calming, sleep, immune or disease claim for this root, on this page or on the label. Health Canada's route for this ingredient is its Traditional Chinese Medicine Ingredients monograph, and the wording that monograph permits is TCM-theory framing - not a symptom benefit. Anything on this page describing traditional use or laboratory research is labelled as exactly that.
See the product & full COA →Ecogenya Chinese Skullcap
Made in Canada, third-party tested.
Chinese Skullcap — for you
Shop Chinese SkullcapSide effects & safety
- Liver injury - read this first: Supplements containing Chinese skullcap have been linked to cases of acute liver injury. LiverTox gives skullcap a likelihood score of B: very likely but rare cause of clinically apparent liver injury. The clearest reports involve combination joint products - Move Free Advanced (Chinese skullcap with black catechu) and flavocoxid/Limbrel (baicalin with Acacia catechu), the latter linked to four cases in Annals of Internal Medicine in 2012. Injury typically appeared within weeks to three months and resolved after stopping; one case recurred on restarting. Do not use if you have any liver condition. Stop and see a doctor immediately if you develop yellowing of the eyes or skin, dark urine, unusual fatigue, nausea or right-sided abdominal pain.
- Species confusion is a safety issue: Chinese skullcap (Scutellaria baicalensis, root) is not American skullcap (Scutellaria lateriflora, aerial parts). Different chemistry, different traditional use, different Health Canada monograph. LiverTox notes over 200 Scutellaria species with different components, activities and potential toxicities. Adulteration has also occurred - the hepatotoxic plant germander has been found substituted for skullcap in suspected liver-injury cases. Buy on the Latin binomial and plant part, never on the word 'skullcap' alone.
- Sedatives, sleep aids and alcohol: Laboratory work suggests some of the root's flavonoids influence GABA receptor activity, and wogonin has shown anticonvulsant effects in animals. Health Canada treats combinations with additive sedative effects as needing higher-tier review. Do not combine with sedatives, sleeping medication, benzodiazepines or alcohol without medical advice.
- Pregnancy, breastfeeding and under 18: Health Canada's TCM Ingredients monograph carries a flat contraindication: do not use if you are pregnant or breastfeeding. The monograph applies to adults 18 years and older only.
- Prescription medications, CYP enzymes and transporters: In healthy volunteers, baicalin reduced blood levels of the statin rosuvastatin (Fan 2008). In lab studies wogonin inhibits CYP1A2 and CYP2C19, and baicalein, baicalin and wogonin inhibit solute carrier transporters that move drugs into cells. Clinical relevance for several of these is undetermined. Health Canada requires you to consult a practitioner before use if you take prescription medications.
- Blood thinners and surgery: Baicalin shows antiplatelet, anticoagulant and profibrinolytic activity in laboratory models, so MSK lists warfarin and other blood thinners under 'do not take if'. Consider pausing well before any planned surgery.
- Blood sugar and blood pressure: Health Canada flags combinations with additive glucose-modifying or blood-pressure-lowering effects as requiring higher-tier review. If you take medication for either, speak to your prescriber first.
- Other reported reactions: Pneumonitis (lung inflammation) has been reported with skullcap-containing preparations, in one case alongside liver injury. A phase I study of baicalein tablets in healthy volunteers flagged possible rises in high-sensitivity C-reactive protein and triglycerides as worth monitoring.
- Duration: Ask a health care practitioner before prolonged use, and stop and consult if symptoms persist, worsen, or new symptoms develop.
References
Every graded claim links to its source; here they are together.
- Traditional Chinese Medicine use: Health Canada NNHPD, Traditional Chinese Medicine Ingredients monograph (May 2025)
- Joint comfort: Arjmandi 2014, J Med Food
- Antioxidant & inflammation: MSK About Herbs: Scutellaria baicalensis
- Blood sugar & metabolism: Shin 2020, Am J Physiol Endocrinol Metab
- Calm, stress & sleep: Brock 2014, Phytotherapy Research (American skullcap, S. lateriflora)
- LiverTox: Skullcap (NIDDK)
- LiverTox: Skullcap (NIDDK)
- MSK About Herbs: Scutellaria baicalensis - herb-drug interactions
- Brock 2014, Phytotherapy Research (American skullcap)
- MSK About Herbs: Scutellaria baicalensis